DJIA 17,050.75 138.46 0.82%
NASDAQ 4,810.79 19.64 0.41%
S&P 500 2,013.43 17.60 0.88%
market minute promo

Roche Holding Ltd. (ADR) (NASDAQOTH: RHHBY)

company name or ticker
Company Photos
(Click to zoom)

Pssst... Pfizer Just Told Investors That This is the Next Big Thing

Pfizer Inc.'s acquisition of Hospira could signal that investors should embrace biosimilar drugmakers.

Could This Disruptive New Technology Lead to a Cure for Cancer?

Major drugmakers are investing heavily in a disruptive technology that could lead to game-changing breakthroughs in the treatment of cancer. Here's what you need to know.

Why Shares of Exelixis, Inc. Briefly Spiked Higher

Exelixis shares popped briefly Thursday. Here's why.

Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?

Pfizer has jumped into the promising field of cancer immunotherapy with both feet. Is this effort too little, too late for the pharma giant?

Upcoming FDA Decisions We're Most Excited About

Three Motley Fool experts tell readers what upcoming FDA decisions have caught their eye.

The Small-Cap Biotech Stock You Should Be Watching

Motley Fool experts offer up insight into three intriguing small-cap biotech stocks.

What are Penny Stocks?

Penny stocks have a popular allure, but the risks are bigger than you think. Here's why you should tread carefully.

Game-Changing News: Researchers May Have Discovered the Cause of Intestinal Cancer

Did researchers really uncover the mechanism behind intestinal cancer formation? Find out what game-changing news this latest study brings to light and how this could help drug developers plan their attack against intestinal cancers.

Why Exelixis Inc.'s Shares Soared Higher Today

Exelixis is rallying ahead of its presentation at a Wall Street healthcare conference tomorrow.

AstraZeneca plc Beefs Up Precision Medicine Arsenal

AstraZeneca upped the ante in precision medicine with the announcement of four new collaborations.
See More Articles...